Restructural changes are effective immediately
The editorial teams of Pharmaceutical Executive and Pharmaceutical Commerce are excited to announce the following updates:
Mike Hollan ([email protected]) has been named Editor of Pharmaceutical Executive, handling the Technology and Leadership columns, as well as general industry articles and interviews.
Meg Rivers ([email protected]) has been named Managing Editor of Pharmaceutical Executive, responsible for the the day-to-day management and content direction of the brand. Formerly Senior Editor for our sister brand Pharmaceutical Technology since June 2021, Meg interviews industry leaders for print and online features, roundtables, and conferences, in addition to managing/co-hosting the biweekly Pharmaceutical Executive Podcast.
Nico Saraceno ([email protected]) has been promoted to Editor of Pharmaceutical Commerce. As Associate Editor since October 2020, Nico has successfully produced the Pharmaceutical Commerce Podcast, taken on increasing responsibilities, and is now leading the day-to-day content management of the brand.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.